Details for Patent: 6,294,197

✉ Email this page to a colleague

Summary for Patent: 6,294,197

Scope and claims summary:

Title:	Solid oral dosage forms of valsartan
Abstract:	The present invention is concerned with solid dosage forms comprising a) valsartan and optionally HCTZ, and b) pharmaceutically acceptable additives suitable for the preparation of solid oral dosage forms by compression methods.
Inventor(s):	Wagner; Robert Frank (Neshanic Station, NJ), Katakuse; Yoshimitsu (Hirakata, JP), Taike; Takashi (Kobe, JP), Yamato; Fujiki (Takarazuka, JP), Kohlmeyer; Manfred (Basel, CH)
Assignee:	Novartis AG (Basel, CH)
Application Number:	09/202,805
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,294,197
Patent Claim Types: see list of patent claims	Dosage form; Process; Use;

Drugs Protected by US Patent 6,294,197

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,294,197

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	9613470	Jun 27, 1996

PCT Information
PCT Filed	June 18, 1997	PCT Application Number:	PCT/EP97/03172
PCT Publication Date:	December 31, 1997	PCT Publication Number:	WO97/49394

International Family Members for US Patent 6,294,197

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	008618	⤷ Subscribe
Argentina	059324	⤷ Subscribe
Austria	276750	⤷ Subscribe
Austria	371449	⤷ Subscribe
Austria	446749	⤷ Subscribe
Australia	3340297	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.